{
    "2018-05-18": [
        [
            {
                "time": "",
                "original_text": "沃森生物一单抗药物获临床试验批件",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "单抗药物",
                        "临床试验",
                        "批件"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：子公司注射用GB251单抗药物获得药物临床试验批件",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "子公司",
                        "注射用GB251",
                        "单抗药物",
                        "临床试验",
                        "批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}